Share: Facebook Twitter LinkedIn
Activity Provided By:

CEimpact

Delafloxacin: A bigger and better fluoroquinolone?

Access Activity

Overview / Abstract:

This application-based continuing pharmacy education activity will provide a "journal club format" discussion for pharmacists and student pharmacists ondelafloxacin, a fluoroquinolone recently approved by the FDA approved for skinand soft tissue infections. Join us to discuss the key trial leading to its approval as well as highlight clinical pearls to clarify its place in therapy for patients in your practice.

Expiration

Jun 03, 2021

Discipline(s)

Pharmacy CPE

Format

Online, Webinar / Webcast / Video

Cost

$9.00

Credits / Hours

0.15

Accreditation

ACPE

Presenters / Authors / Faculty

Christina Rivera, PharmD, BCPS
MTM Pharmacist - Infectious Disease Clinic
Mayo Clinic - Rochester

Keywords / Search Terms

CEI ce, law, federal, pharmacy, update, legislative, regulatory, pbm, provider status, act

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map